Drawing for MACROFLUX

USPTO serial 75472283

MACROFLUX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DWYER, JOHN D
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MACROFLUX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

D. BYRON MILLER

D BYRON MILLER ALZA CORP1900 CHARLESTON RD M10-3P O BOX 7210MOUNTAIN VIEW, CA 94039-7210

Goods and services

ClassDescriptionStatusFirst use
005Transdermal patches for sampling glucose, sold without medication; transdermal drug patches sold with medication; iontophoretic drug delivery devices, namely, iontophoresis electrodes, iontophoresis dispersive pads, and iontophoresis apparatus which generates an electric current for the delivery of drugs through the skin, sold with medication; intradermal drug delivery devices sold with medicationACTIVE—
010Iontophoretic drug delivery devices, namely, iotophoresis electrodes, iontophoresis dispersive pads, and iontophoresis apparatus which generates an electric current for the delivery of drugs through the skin, sold without medication; intradermal drug delivery devices sold without medicationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 5, 2002EX4GSOU EXTENSION 4 GRANTED—
Dec 21, 2001PETGPETITION TO REVIVE-GRANTED—
Aug 27, 2001EXT4SOU EXTENSION 4 FILED—
Jun 10, 2001EX3GSOU EXTENSION 3 GRANTED—
May 25, 2001ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 25, 2001ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 30, 2001PETRPETITION TO REVIVE-RECEIVED—
Mar 1, 2001EXT3SOU EXTENSION 3 FILED—
Oct 27, 2000EX2GSOU EXTENSION 2 GRANTED—
Aug 29, 2000EXT2SOU EXTENSION 2 FILED—
Apr 21, 2000EX1GSOU EXTENSION 1 GRANTED—
Feb 18, 2000EXT1SOU EXTENSION 1 FILED—
Aug 31, 1999NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 8, 1999PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 7, 1999NPUBNOTICE OF PUBLICATION—
Mar 11, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 26, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 19, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 1999DOCKASSIGNED TO EXAMINER—
Dec 21, 1998DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance